Lu Xia
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in ⓘ
-
- Tuberculosis Research and Epidemiology 13
- COVID-19 Clinical Research Studies 7
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Co-authors
- Yun Ling (5 shared papers)Jun Chen (3 shared papers)Qingnian Xu (3 shared papers)Dan Huang (3 shared papers)Li Liu (2 shared papers)Shuli Song (2 shared papers)Xiong‐Fei Pan (2 shared papers)Jing Wang (2 shared papers)
- Journals
- Open Forum Infectious Diseases (4 papers)Advances in experimental medicine and biology (3 papers)Frontiers in Psychology (3 papers)Scientific Reports (2 papers)International Journal of Infectious Diseases (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Lu Xia
64 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Infectious Diseases 653
- Neurology 262
- Biophysics 58
- Cancer Research 152
- Orthopedics and Sports Medicine 86
Countries citing papers authored by Lu Xia
This map shows the geographic impact of Lu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Xia more than expected).
Fields of papers citing papers by Lu Xia
This network shows the impact of papers produced by Lu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Xia. The network helps show where Lu Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Hit paper breakdown → | 2020 | 490 |
| 2 | 2019 | 213 | |
| 3 | Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies Hit paper breakdown → | 2020 | 182 |
| 4 | 2011 | 92 | |
| 5 | 2020 | 90 | |
| 6 | 2012 | 72 | |
| 7 | 2020 | 66 | |
| 8 | 2012 | 42 | |
| 9 | 2011 | 41 | |
| 10 | 2016 | 33 | |
| 11 | 2016 | 33 | |
| 12 | 2015 | 33 | |
| 13 | 2016 | 29 | |
| 14 | 2020 | 25 | |
| 15 | 2019 | 24 | |
| 16 | 2018 | 24 | |
| 17 | 2018 | 24 | |
| 18 | 2015 | 23 | |
| 19 | 2013 | 19 | |
| 20 | 2019 | 18 |
About Lu Xia
Lu Xia is a scholar working on Infectious Diseases, Cancer Research, Complementary and alternative medicine, Immunology and Epidemiology, having authored 74 papers that have together received 1.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (13 papers), COVID-19 Clinical Research Studies (7 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Infectious Diseases and Tuberculosis (5 papers), Long-Term Effects of COVID-19 (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Infectious Diseases (653 citations), Neurology (262 citations), Biophysics (58 citations), Cancer Research (152 citations) and Orthopedics and Sports Medicine (86 citations). Lu Xia has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yun Ling, Jun Chen, Qingnian Xu, Dan Huang, Li Liu, Shuli Song, Xiong‐Fei Pan, Jing Wang, Junxiang Chen and Huiqi Li. Their work appears in journals such as Open Forum Infectious Diseases, Advances in experimental medicine and biology, Frontiers in Psychology, Scientific Reports and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.